SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001213900-23-036661
Filing Date
2023-05-05
Accepted
2023-05-05 09:00:06
Documents
13
Period of Report
2023-05-04
Items
Item 3.02: Unregistered Sales of Equity Securities

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT ea178057-8k_biomxinc.htm   iXBRL 8-K 32454
  Complete submission text file 0001213900-23-036661.txt   261663

Data Files

Seq Description Document Type Size
2 XBRL SCHEMA FILE phge-20230504.xsd EX-101.SCH 4204
3 XBRL DEFINITION FILE phge-20230504_def.xml EX-101.DEF 27449
4 XBRL LABEL FILE phge-20230504_lab.xml EX-101.LAB 38219
5 XBRL PRESENTATION FILE phge-20230504_pre.xml EX-101.PRE 26069
7 EXTRACTED XBRL INSTANCE DOCUMENT ea178057-8k_biomxinc_htm.xml XML 7448
Mailing Address 22 EINSTEIN ST., 4TH FLOOR NESS ZIONA L3 7414003
Business Address 22 EINSTEIN ST., 4TH FLOOR NESS ZIONA L3 7414003 (972) 72 394 2377
BiomX Inc. (Filer) CIK: 0001739174 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38762 | Film No.: 23891491
SIC: 2836 Biological Products, (No Diagnostic Substances)